Susquehanna International Group
PMVP icon

Susquehanna International Group’s PMV Pharmaceuticals PMVP Stock Holding History

Susquehanna International Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33,900
Closed -$105K – 13090
2023
Q4 		$105K Sell
33,900
-250,400
-88% -$663K ﹤0.01% 11290
2023
Q3 		$1.75M Buy
284,300
+266,700
+1,515% +$1.83M ﹤0.01% 5410
2023
Q2 		$110K Sell
17,600
-15,800
-47% -$82.8K ﹤0.01% 10886
2023
Q1 		$159K Sell
33,400
-74,300
-69% -$523K ﹤0.01% 10857
2022
Q4 		$937K Buy
107,700
+76,400
+244% +$814K ﹤0.01% 6341
2022
Q3 		$372K Sell
31,300
-11,900
-28% -$172K ﹤0.01% 9254
2022
Q2 		$616K Sell
43,200
-24,400
-36% -$355K ﹤0.01% 7746
2022
Q1 		$1.41M Buy
+67,600
New +$1.19M ﹤0.01% 6298

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Susquehanna International Group's PMVP Position: Q1 2026 in Review

Susquehanna International Group sold out of PMV Pharmaceuticals (PMVP) in Q1 2026, closing a stake of 78,784 shares — an estimated $98.5K sold.

Susquehanna International Group first reported a position in PMVP in Q2 2021 and held it in 17 quarters. The position peaked at $1.63M in Q1 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Susquehanna International Group reported no remaining PMV Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 78,784 PMV Pharmaceuticals shares in Q1 2026, an estimated $98.5K.
  • Susquehanna International Group first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Susquehanna International Group's PMV Pharmaceuticals position peaked at $1.63M in Q1 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.